Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of BLASTX in Catheter Associated Bacteriuria Versus Standard of Care (SOC)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. 18 years or older~2. Absence of symptomatic UTI~3. Absence of upper/lower tract obstructions~4. No known allergies to the study products~5. Willing to comply with all study procedures and available for the duration of the study~Exclusion Criteria:~1. 17 years or younger~2. Symptomatic UTI~3. Presence of upper/lower tract obstructions~4. Known allergic reaction to the study products~5. Unable to provide signed and dated informed consent form

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- BLASTX Lubricated Catheter (Type: EXPERIMENTAL): Subjects for which catheterization is prescribed will be catheterized with a Foley lubricated with BLASTX. This gel lubricates with the same viscosity as McKesson Jelly and has a biofilm disruptive active ingredient.
- McKesson Jelly Lubricated Catheter (Type: PLACEBO_COMPARATOR): Subjects for which catheterization is prescribed will be catheterized with a Foley lubricated with McKesson Jelly. This jelly lubricates with the same viscosity as BLASTX but has no biofilm disruptive active ingredient.

Based on this trial design, predict the completion outcome and termination type (if applicable).